Jasbir Seehra

Director & CHIEF EXECUTIVE OFFICER

Director & CHIEF EXECUTIVE OFFICER at Keros Therapeutics, Inc., filing insider transactions on 2026-02-19.

Total Purchases

—

0 transactions

Total Sales

$113K

1 transaction

Companies Traded

1 total filings

Active Since

2026-02-19

Last: 2026-02-19

Companies

Keros Therapeutics, Inc.

Date	Ticker	Type	Shares	Price	Value	Owned After
2026-02-19	KROS	Sale	7,015	$16.17	$113K	385.7K	SEC ↗